Verhamme C - Search Results

1

A double-blind, placebo-controlled, randomized trial of PXT3003 for the treatment of Charcot-Marie-Tooth type 1A.

Attarian S, Young P, Brannagan TH, Adams D, Van Damme P, Thomas FP, Casanovas C, Kafaie J, Tard C, Walter MC, Péréon Y, Walk D, Stino A, de Visser M, Verhamme C, Amato A, Carter G, Magy L, Statland JM, Felice K. Attarian S, et al. Among authors: verhamme c. Orphanet J Rare Dis. 2021 Oct 16;16(1):433. doi: 10.1186/s13023-021-02040-8. Orphanet J Rare Dis. 2021. PMID: 34656144 Free PMC article. Clinical Trial.

2

Clinical disease severity and axonal dysfunction in hereditary motor and sensory neuropathy Ia.

Verhamme C, van Schaik IN, Koelman JH, de Haan RJ, Vermeulen M, de Visser M. Verhamme C, et al. J Neurol. 2004 Dec;251(12):1491-7. doi: 10.1007/s00415-004-0578-x. J Neurol. 2004. PMID: 15645349

3

Comparison of CMT1A and CMT2: similarities and differences.

Bienfait HM, Verhamme C, van Schaik IN, Koelman JH, de Visser BW, de Haan RJ, Baas F, van Engelen BG, de Visser M. Bienfait HM, et al. Among authors: verhamme c. J Neurol. 2006 Dec;253(12):1572-80. doi: 10.1007/s00415-006-0260-6. Epub 2006 Aug 28. J Neurol. 2006. PMID: 16941080

4

The natural history of Charcot-Marie-Tooth type 1A in adults: a 5-year follow-up study.

Verhamme C, van Schaik IN, Koelman JH, de Haan RJ, de Visser M. Verhamme C, et al. Brain. 2009 Dec;132(Pt 12):3252-62. doi: 10.1093/brain/awp251. Brain. 2009. PMID: 19843647

5

Oral high dose ascorbic acid treatment for one year in young CMT1A patients: a randomised, double-blind, placebo-controlled phase II trial.

Verhamme C, de Haan RJ, Vermeulen M, Baas F, de Visser M, van Schaik IN. Verhamme C, et al. BMC Med. 2009 Nov 12;7:70. doi: 10.1186/1741-7015-7-70. BMC Med. 2009. PMID: 19909499 Free PMC article. Clinical Trial.

6

Tripod pinch strength and thumb opposition are the major determinants of manual dexterity in Charcot-Marie-Tooth disease type 1A.

Videler AJ, Beelen A, van Schaik IN, Verhamme C, van den Berg LH, de Visser M, Nollet F. Videler AJ, et al. Among authors: verhamme c. J Neurol Neurosurg Psychiatry. 2010 Aug;81(8):828-33. doi: 10.1136/jnnp.2009.187302. Epub 2010 Jun 18. J Neurol Neurosurg Psychiatry. 2010. PMID: 20562406

7

Ascorbic acid for treatment in CMT1A: what's next?

de Visser M, Verhamme C. de Visser M, et al. Among authors: verhamme c. Lancet Neurol. 2011 Apr;10(4):291-3. doi: 10.1016/S1474-4422(11)70042-4. Lancet Neurol. 2011. PMID: 21393064 No abstract available.

8

The phenotype of the Gly94fsX222 PMP22 insertion.

de Vries SD, Verhamme C, van Ruissen F, van Paassen BW, Arts WF, Kerkhoff H, van Engelen BG, Lammens M, de Visser M, Baas F, van der Kooi AJ. de Vries SD, et al. Among authors: verhamme c. J Peripher Nerv Syst. 2011 Jun;16(2):113-8. doi: 10.1111/j.1529-8027.2011.00333.x. J Peripher Nerv Syst. 2011. PMID: 21692910

9

X-linked adrenoleukodystrophy in women: a cross-sectional cohort study.

Engelen M, Barbier M, Dijkstra IM, Schür R, de Bie RM, Verhamme C, Dijkgraaf MG, Aubourg PA, Wanders RJ, van Geel BM, de Visser M, Poll-The BT, Kemp S. Engelen M, et al. Among authors: verhamme c. Brain. 2014 Mar;137(Pt 3):693-706. doi: 10.1093/brain/awt361. Epub 2014 Jan 29. Brain. 2014. PMID: 24480483

10

van Paassen BW, van der Kooi AJ, van Spaendonck-Zwarts KY, Verhamme C, Baas F, de Visser M. van Paassen BW, et al. Among authors: verhamme c. Orphanet J Rare Dis. 2014 Mar 19;9:38. doi: 10.1186/1750-1172-9-38. Orphanet J Rare Dis. 2014. PMID: 24646194 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters